Malaria Radical Cure Drug Efficacy Clinical Study

Notice ID: edc7c95b3da447c7badd45bb67507a4fNAICS: 541715

Posted: Closed on Mar 12, 2026Response Deadline: Closed on Apr 25, 2026

Set-Aside

No Set aside used

NAICS

541715

Days to Deadline

Key Details

Department

DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY

NAICS Code

541715

Set-Aside Type

No Set aside used

Description

The full description, scope of work, and requirements for this opportunity are available on SAM.gov.

View Full Description on SAM.gov

Context & Analysis

DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY posted this opportunity on Mar 12, 2026. It is classified as a special notice notice. Work falls under NAICS 541715. No set-aside applies, so the competition is open to businesses of any size. The response deadline (Apr 25, 2026) has passed.

About this market

Department of Defense awards in NAICS 541715 over the last 3 years.

Typical award size: The median award was $884K; the middle half ran from $500 to $4.5M (3193 priced awards).
Competition: 94% of 435 awards were competed; median 999 offers.
Largest vendors: FLUOR MARINE PROPULSION, LLC — 2 awards, $27.8B
LOCKHEED MARTIN CORP — 10 awards, $21.0B
THE MITRE CORPORATION — 12 awards, $5.3B
LOCKHEED MARTIN CORPORATION — 3 awards, $4.8B
Largest recent awards: $14.2B to FLUOR MARINE PROPULSION, LLC, signed Nov 20, 2025
$6.3B to LOCKHEED MARTIN CORP, signed Dec 2, 2025
$4.6B to LOCKHEED MARTIN CORPORATION, signed Nov 14, 2025
$4.0B to LOCKHEED MARTIN CORP, signed Nov 25, 2025
$1.7B to LOCKHEED MARTIN CORPORATION, signed Oct 8, 2025
Recompete pipeline: 417 contracts of $100K or more in this market end between 90 days and 18 months from now.